Fiebach, Jochen B.

Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

Vandenberghe, R., Rinne, J. O., Boada, M., Katayama, S., Scheltens, P., Vellas, B., Tuchman, M., Gass, A., Fiebach, J. B., Hill, D., et al. (2016) · Alzheimer's Research & Therapy

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 304

Opening the black box of artificial intelligence for clinical decision support: A study predicting stroke outcome

Zihni, E., Madai, V. I., Livne, M., Galinovic, I., Khalil, A. A., Fiebach, J. B., & Frey, D. (2020) · PLOS ONE

Explainable Artificial Intelligence (XAI)Artificial Intelligence in Healthcare

Cited by 187

DCE-MRI blood–brain barrier assessment in acute ischemic stroke

Villringer, K., Sanz Cuesta, B. E., Ostwaldt, A.-C., Grittner, U., Brunecker, P., Khalil, A. A., Schindler, K., Eisenblätter, O., Audebert, H., & Fiebach, J. B. (2017) · Neurology

Barrier Structure and Function StudiesAcute Ischemic Stroke Management

Cited by 119